Bryan Clemons
Impact in
-
- Neuropeptides and Animal Physiology
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling
- Sphingolipid Metabolism and Signaling
- Lipid Membrane Structure and Behavior
- Inflammasome and immune disorders
Papers in
-
- Sphingolipid Metabolism and Signaling 6
- Lipid Membrane Structure and Behavior 2
- Receptor Mechanisms and Signaling 2
-
- Pulmonary Hypertension Research and Treatments 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Fiona L. Scott (7 shared papers)Hugh Rosen (4 shared papers)Stuart M. Cahalan (2 shared papers)Mark T. Griffith (1 shared paper)Raymond C. Stevens (1 shared paper)Gye Won Han (1 shared paper)C. Roth (1 shared paper)Peter Kühn (1 shared paper)
- Journals
- Neurology (2 papers)Gastroenterology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Science (1 paper)
- Partner nations
- United StatesSwedenNorway
In The Last Decade
Bryan Clemons
12 papers receiving 966 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cellular and Molecular Neuroscience 233
- Molecular Biology 751
- Cell Biology 107
- Hematology 67
- Immunology 104
Countries citing papers authored by Bryan Clemons
This map shows the geographic impact of Bryan Clemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Clemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Clemons more than expected).
Fields of papers citing papers by Bryan Clemons
This network shows the impact of papers produced by Bryan Clemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Clemons. The network helps show where Bryan Clemons may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Clemons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Crystal Structure of a Lipid G Protein–Coupled Receptor Hit paper breakdown → | 2012 | 544 |
| 2 | 2016 | 239 | |
| 3 | 2011 | 65 | |
| 4 | 2022 | 49 | |
| 5 | 2008 | 42 | |
| 6 | 2018 | 40 | |
| 7 | 2009 | 6 | |
| 8 | Abstract 11102: Gb002, A Novel Inhaled Pdgfr Kinase Inhibitor, Demonstrates Efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah) | 2019 | 4 |
| 9 | 2013 | 4 | |
| 10 | 2013 | 3 | |
| 11 | 2020 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2012 | 1 |
About Bryan Clemons
Bryan Clemons is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology, Oncology and Cell Biology, having authored 13 papers that have together received 999 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (6 papers), Pulmonary Hypertension Research and Treatments (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Lipid Membrane Structure and Behavior (2 papers), Systemic Lupus Erythematosus Research (2 papers), Receptor Mechanisms and Signaling (2 papers), Renal Diseases and Glomerulopathies (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (233 citations), Molecular Biology (751 citations), Cell Biology (107 citations), Hematology (67 citations) and Immunology (104 citations). Bryan Clemons has collaborated with scholars based in United States, Sweden and Norway. Frequent co-authors include Fiona L. Scott, Hugh Rosen, Stuart M. Cahalan, Mark T. Griffith, Raymond C. Stevens, Gye Won Han, C. Roth, Peter Kühn, Euijung Jo and Marta Sanna. Their work appears in journals such as Neurology, Gastroenterology, Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.